Examkin

Question

Difficulty: HardSubstance-Related and Addictive Disorders

A 28-year-old woman is brought to the emergency department by emergency medical services after she was found severely agitated and combative outside a nightclub. Her friends report that she consumed an unknown "party pill" a few hours ago. The patient has a history of major depressive disorder with past hypomanic episodes, for which she was recently prescribed sertraline by a new primary care physician. She also has a history of opioid use disorder and has been stable on methadone maintenance therapy for two years.

On presentation, she is hallucinating, claiming that "angels are commanding her to fly." Vital signs are temperature 39.4°C (102.9°F), blood pressure 178/108 mm Hg, pulse 142/min, and respirations 24/min. Physical examination reveals marked diaphoresis, mydriasis, and bilateral continuous ankle clonus with generalized hyperreflexia.

Laboratory studies show:
Thyroid-stimulating hormone (TSH): 0.1 µU/mL (normal: 0.4–4.0 µU/mL)
Free thyroxine (T4): 1.3 ng/dL (normal: 0.9–1.7 ng/dL)
Urine toxicology screen is positive for methadone but negative for amphetamines, cocaine, and phencyclidine (PCP).

Which of the following is the most likely diagnosis for this patient's acute presentation?

  1. Substance-induced serotonin toxicityAnswer
  2. B
    Bipolar disorder, manic episode
  3. C
    Brief psychotic disorder
  4. D
    Thyroid storm
  5. E
    Opioid withdrawal syndrome

Answer

Substance-induced serotonin toxicity
The patient's clinical picture of altered mental status, profound autonomic instability (hyperthermia, hypertension, tachycardia), and distinct neuromuscular hyperactivity (hyperreflexia, continuous ankle clonus) forms the classic diagnostic triad of serotonin toxicity (serotonin syndrome). This life-threatening condition was precipitated by the ingestion of an illicit serotonergic substance, such as MDMA (ecstasy) or a synthetic cathinone, which frequently elude routine urine amphetamine screens. The patient's risk was heavily compounded by her baseline use of sertraline (an SSRI) and methadone, both of which increase synaptic serotonin levels. In cases of acute substance-induced toxidromes, identifying the specific interaction between illicit agents and prescribed medications is critical for accurate diagnosis and management.

Step-by-Step Solution

1
Evaluate the patient's vital signs and physical examination for specific toxidrome characteristics.
The patient exhibits severe autonomic instability (temperature 39.4°C, marked hypertension, tachycardia) and neuromuscular hyperactivity (continuous ankle clonus, hyperreflexia).
Identifying the specific pattern of sympathetic overactivity and reflex abnormalities is the critical first step in differentiating toxicologic emergencies.
2
Synthesize the patient's medication history with the acute presentation.
The patient is actively taking sertraline (an SSRI) and methadone (a weak serotonin reuptake inhibitor), both of which increase baseline serotonergic tone.
Polypharmacy often lowers the threshold for drug-induced toxicities, making the patient highly vulnerable to severe pharmacological interactions.
3
Analyze the potential impact of the acutely ingested illicit substance in this context.
The ingested 'party pill' is likely a serotonergic amphetamine analog (such as MDMA/ecstasy), which precipitates massive serotonin release and frequently escapes detection on standard amphetamine urine screens.
Combining a powerful serotonin-releasing illicit agent with baseline reuptake inhibitors triggers life-threatening serotonin syndrome.
4
Rule out competing diagnoses based on lab results and clinical criteria.
Normal free T4 rules out thyroid storm; the presence of clonus and severe hyperthermia definitively rules out isolated opioid withdrawal or a primary manic/psychotic episode.
It is necessary to systematically exclude primary psychiatric and endocrine emergencies before finalizing a toxicologic diagnosis.

Key Concept

Diagnosis of substance-induced toxidromes and recognition of life-threatening pharmacological interactions, specifically serotonin syndrome triggered by MDMA combined with SSRIs.
Estimated Time:2m 0s
Rate this question

Topics

Substance-Related and Addictive Disorders

More questions from this topic